Weight loss study for older adults with obesity
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests a new combination of two medications to help older adults with obesity lose weight. It aims to see if adding LUM-201 to semaglutide improves weight loss compared to semaglutide alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 60 and 84 years old.
- Your body mass index (BMI) is 30 or higher.
- You have tried to lose weight through diet before.
- You do not have diabetes.
- You have not used certain weight-loss or diabetes medications recently.
- You are generally healthy and able to walk and move around.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if adding a natural compound called 20E (20-hydroxyecdysone) to the weight-loss drug semaglutide can help people with obesity lose more weight and keep muscle. You would take both medications and follow a diet and exercise plan.
This study tests an investigational medication, called NNC0721-8060, to see how it works in people with excess weight (overweight or obesity). It may help with weight loss, but is still in early human testing.
This study tests an oral medicine (semaglutide) to see if it helps adults with excess weight lose weight. It might offer an easier, pill-based treatment option for weight management.
This study tests a nasal spray containing semaglutide (a GLP-1 receptor agonist) to see if it helps adults who are overweight or obese lose weight. It may be an option if you have a BMI between 27 and 35 and have not used other weight loss medications recently.
This study tests a new medicine called NNC0487-0111 to see how well it helps people with excess body weight and type 2 diabetes lose weight, compared to another medicine called semaglutide. It may be an option if you have type 2 diabetes and are looking to manage your weight.
This study tracks how semaglutide (an injectable medication that reduces appetite) helps adults lose weight in everyday life. Researchers want to understand how well it works and how safe it is for people starting the treatment.
Hear when a new Obesity & Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.